• Home
  • Food and Beverage
Dynamics in Post-pandemic Global Human Milk Oligosaccharides (HMO) Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Human Milk Oligosaccharides (HMO) Industry: Supply and Demand, Markets and Prices 2021-2027

Report Code: KNJ702276 | No. of Pages: 132 | Category: Food and Beverage
Publisher: GRD Survey | Date of Publish: Apr-2021 
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Human Milk Oligosaccharides (HMO) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Human Milk Oligosaccharides (HMO) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
2'-FL & 3-FL

Sialyllactose

LNT & LNnT

The segment of 2'-FL & 3-FL holds a comparatively larger share in global market, which accounts for about 70%.

Segmented by End User/Segment
Infant Formula

Functional Food & Beverages

Food/Medical Supplements

Other

The baby formula holds an important share in terms of applications, and accounts for 70% of the market share.

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
ZuChem

Jennewein Biotechnologie

Inbiose

Glycom

Elicityl SA

Dextra Laboratories

Abbott



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Human Milk Oligosaccharides (HMO) Market Status and Forecast (2016-2027)
        1.3.2 Global Human Milk Oligosaccharides (HMO) Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Human Milk Oligosaccharides (HMO) Supply by Company
    2.1 Global Human Milk Oligosaccharides (HMO) Sales Volume by Company
    2.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Company
    2.3 Global Human Milk Oligosaccharides (HMO) Price by Company
    2.4 Human Milk Oligosaccharides (HMO) Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Human Milk Oligosaccharides (HMO) Market Status by Category
    3.1 Human Milk Oligosaccharides (HMO) Category Introduction
        3.1.1 2'-FL & 3-FL

        3.1.2 Sialyllactose

        3.1.3 LNT & LNnT

        3.1.4 The segment of 2'-FL & 3-FL holds a comparatively larger share in global market, which accounts for about 70%.
    3.2 Global Human Milk Oligosaccharides (HMO) Market by Category
        3.2.1 Global Human Milk Oligosaccharides (HMO) Sales Volume by Category (2016-2021)
        3.2.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Category (2016-2021)
        3.2.3 Global Human Milk Oligosaccharides (HMO) Price by Category (2016-2021)
    3.3 North America: by Category
    3.4 Europe: by Category
    3.5 Asia Pacific: by Category
    3.6 Central & South America: by Category
    3.7 Middle East & Africa: by Category
4 Global and Regional Human Milk Oligosaccharides (HMO) Market Status by End User/Segment
    4.1 Human Milk Oligosaccharides (HMO) Segment by End User/Segment
        4.1.1 Infant Formula

        4.1.2 Functional Food & Beverages

        4.1.3 Food/Medical Supplements

        4.1.4 Other

        4.1.5 The baby formula holds an important share in terms of applications, and accounts for 70% of the market share.
    4.2 Global Human Milk Oligosaccharides (HMO) Market by End User/Segment
        4.2.1 Global Human Milk Oligosaccharides (HMO) Sales Volume by End User/Segment (2016-2021)
        4.2.2 Global Human Milk Oligosaccharides (HMO) Sales Value by End User/Segment (2016-2021)
        4.2.3 Global Human Milk Oligosaccharides (HMO) Price by End User/Segment (2016-2021)
    4.3 North America: by End User/Segment
    4.4 Europe: by End User/Segment
    4.5 Asia Pacific: by End User/Segment
    4.6 Central & South America: by End User/Segment
    4.7 Middle East & Africa: by End User/Segment
5 Global Human Milk Oligosaccharides (HMO) Market Status by Region
    5.1 Global Human Milk Oligosaccharides (HMO) Market by Region
        5.1.1 Global Human Milk Oligosaccharides (HMO) Sales Volume by Region
        5.1.2 Global Human Milk Oligosaccharides (HMO) Sales Value by Region
    5.2 North America Human Milk Oligosaccharides (HMO) Market Status
    5.3 Europe Human Milk Oligosaccharides (HMO) Market Status
    5.4 Asia Pacific Human Milk Oligosaccharides (HMO) Market Status
    5.5 Central & South America Human Milk Oligosaccharides (HMO) Market Status
    5.6 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Status
6 North America Human Milk Oligosaccharides (HMO) Market Status
    6.1 North America Human Milk Oligosaccharides (HMO) Market by Country
        6.1.1 North America Human Milk Oligosaccharides (HMO) Sales Volume by Country (2016-2021)
        6.1.2 North America Human Milk Oligosaccharides (HMO) Sales Value by Country (2016-2021)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Human Milk Oligosaccharides (HMO) Market Status
    7.1 Europe Human Milk Oligosaccharides (HMO) Market by Country
        7.1.1 Europe Human Milk Oligosaccharides (HMO) Sales Volume by Country (2016-2021)
        7.1.2 Europe Human Milk Oligosaccharides (HMO) Sales Value by Country (2016-2021)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Human Milk Oligosaccharides (HMO) Market Status
   8.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market by Country
        8.1.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales Volume by Country (2016-2021)
        8.1.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales Value by Country (2016-2021)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Human Milk Oligosaccharides (HMO) Market Status
    9.1 Central & South America Human Milk Oligosaccharides (HMO) Market by Country
        9.1.1 Central & South America Human Milk Oligosaccharides (HMO) Sales Volume by Country (2016-2021)
        9.1.2 Central & South America Human Milk Oligosaccharides (HMO) Sales Value by Country (2016-2021)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Status
    10.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Market by Country
        10.1.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Volume by Country (2016-2021)
        10.1.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Sales Value by Country (2016-2021)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Human Milk Oligosaccharides (HMO) Manufacturing Cost Analysis
    11.5 Human Milk Oligosaccharides (HMO) Sales Channel and Distributors Analysis
        11.5.1 Human Milk Oligosaccharides (HMO) Sales Channel
        11.5.2 Human Milk Oligosaccharides (HMO) Distributors
    11.6 Human Milk Oligosaccharides (HMO) Downstream Major Buyers
12 Global Human Milk Oligosaccharides (HMO) Market Forecast by Category and by End User/Segment
    12.1 Global Human Milk Oligosaccharides (HMO) Sales Volume and Sales Value Forecast (2022-2027)
    12.2 Global Human Milk Oligosaccharides (HMO) Forecast by Category
        12.2.1 Global Human Milk Oligosaccharides (HMO) Sales Volume Forecast by Category
        12.2.2 Global Human Milk Oligosaccharides (HMO) Sales Value Forecast by Category
        12.2.3 Global Human Milk Oligosaccharides (HMO) Price Forecast by Category
    12.3 Global Human Milk Oligosaccharides (HMO) Forecast by End User/Segment
        12.3.1 Global Human Milk Oligosaccharides (HMO) Sales Volume Forecast by End User/Segment
        12.3.2 Global Human Milk Oligosaccharides (HMO) Sales Value Forecast by End User/Segment
        12.3.3 Global Human Milk Oligosaccharides (HMO) Price Forecast by End User/Segment
13 Global Human Milk Oligosaccharides (HMO) Market Forecast by Region/Country
    13.1 Global Human Milk Oligosaccharides (HMO) Market Forecast by Region (2022-2027)
        13.1.1 Global Human Milk Oligosaccharides (HMO) Sales Volume Forecast by Region (2022-2027)
        13.1.2 Global Human Milk Oligosaccharides (HMO) Sales Value Forecast by Region (2022-2027)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 ZuChem

        14.1.1 Company Information
        14.1.2 Human Milk Oligosaccharides (HMO) Product Introduction
        14.1.3 ZuChem
 Human Milk Oligosaccharides (HMO) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.1.4 SWOT Analysis
    14.2 Jennewein Biotechnologie

        14.2.1 Company Information
        14.2.2 Human Milk Oligosaccharides (HMO) Product Introduction
        14.2.3 Jennewein Biotechnologie
 Human Milk Oligosaccharides (HMO) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.2.4 SWOT Analysis
    14.3 Inbiose

        14.3.1 Company Information
        14.3.2 Human Milk Oligosaccharides (HMO) Product Introduction
        14.3.3 Inbiose
 Human Milk Oligosaccharides (HMO) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.3.4 SWOT Analysis
    14.4 Glycom

        14.4.1 Company Information
        14.4.2 Human Milk Oligosaccharides (HMO) Product Introduction
        14.4.3 Glycom
 Human Milk Oligosaccharides (HMO) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.4.4 SWOT Analysis
    14.5 Elicityl SA

        14.5.1 Company Information
        14.5.2 Human Milk Oligosaccharides (HMO) Product Introduction
        14.5.3 Elicityl SA
 Human Milk Oligosaccharides (HMO) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.5.4 SWOT Analysis
    14.6 Dextra Laboratories

        14.6.1 Company Information
        14.6.2 Human Milk Oligosaccharides (HMO) Product Introduction
        14.6.3 Dextra Laboratories
 Human Milk Oligosaccharides (HMO) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.6.4 SWOT Analysis
    14.7 Abbott

        14.7.1 Company Information
        14.7.2 Human Milk Oligosaccharides (HMO) Product Introduction
        14.7.3 Abbott
 Human Milk Oligosaccharides (HMO) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.7.4 SWOT Analysis
    ...
15 Conclusion
16 Methodology


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com